$ENTB Our goal is to utilize small molecule thera
Post# of 5409
(Total Views: 106)
Posted On: 02/06/2017 8:34:58 AM
$ENTB Our goal is to utilize small molecule therapies for treating autoimmune disorders (arthritis) in animal companions, feline leukemia (cats) and canine cancer (dogs). Currently, Zander Therapeutics is developing products treating blood disorders using small molecules based on nuclear receptor NR2F6 under an exclusive license agreement for veterinary use from Regen BioPharma Inc. (OTCQB: RGBP).
http://www.zandertherapeutics.com/
http://www.zandertherapeutics.com/
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼